Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

Participants will receive a single IV dose at start of conditioning

The device used to remove the αβ+T cells from donor stem cell transplant before being given to the recipient

TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic cells will be administered by IV after completion of conditioning regimen.

3 consecutive daily doses of rATG will be given by IV during conditioning

4 consecutive daily doses of cyclophosphamid will be given by IV during conditioning

4 consecutive daily doses of fludarabine will be given by IV during conditioning

1 dose of rituximab will be given at the end of conditioning